Skip to main content

Table 2 Results

From: Favorable impact of long-term exercise on disease symptoms in pediatric patients with inflammatory bowel disease

 

IBD-AD

IBD-RE

HC

Time

Group

Group x Time

(n = 7)

(n = 14)

(n = 23)

Pretest (M)

Posttest (M)

Pretest (M)

Posttest (M)

Pretest (M)

Posttest (M)

F

p

ηp 2

F

p

ηp 2

F

p

ηp 2

Inflammation before and after a single bout of exercise

 ESR

11.83 ± 8.06

9.67 ± 7.4

11.83 ± 13.17

8.5 ± 10.11

6.05 ± 6.57

7.59 ± 9.42

0.61

.44

0.02

0.97

.39

0.05

1.19

.32

0.06

 Albumin

19.36 ± 17.79

20.04 ± 18.57

20.37 ± 18.77

21.08 ± 19.5

21.49 ± 18.63

22.36 ± 19.44

17.80

.00

0.30

0.05

.96

0.00

0.13

.88

0.01

 CRP

4.44 ± 5.57

4.52 ± 5.7

3.02 ± 4.56

3.02 ± 4.51

0.67 ± 0.84

0.7 ± 0.84

1.91

.18

0.05

4.10

.02

0.18

0.85

.43

0.04

 Cortisol

289.75 ± 159.82

285.63 ± 191.25

248.31 ± 138.53

242 ± 146.79

203.83 ± 109.8

208.35 ± 104.4

0.06

.81

0.00

1.26

.29

0.06

0.23

.80

0.01

 Hemoglobin

126 ± 19.57

129.88 ± 21.03

135.31 ± 15.63

135.77 ± 15.88

135.91 ± 12.05

136.78 ± 13.57

8.05

.01

0.16

0.96

.39

0.04

2.42

.10

0.11

 Erytrozytes

4.78 ± 0.28

4.93 ± 0.25

4.87 ± 0.51

4.90 ± 0.52

4.87 ± 0.35

4.89 ± 0.37

11.86

.00

0.22

0.01

.99

0.00

3.23

.05

0.14

 Hematocrit

37.06 ± 4.13

38.29 ± 4.2

38.17 ± 3.83

38.62 ± 3.98

38.7 ± 3.11

39.02 ± 3.41

17.71

.00

0.30

0.33

.72

0.02

2.71

.08

0.12

 Thrombocytes

416.5 ± 181.38

402.13 ± 102.78

310.46 ± 60.80

334.85 ± 68.85

270.87 ± 45.59

293.52 ± 55.62

1.88

.18

0.04

8.38

.00

0.29

2.01

.15

0.09

 Leukocytes

9.5 ± 1.93

11.05 ± 2.2

9.28 ± 2.71

10.75 ± 3.11

8.23 ± 1.26

9.46 ± 1.95

38.54

.00

0.48

2.14

.13

0.09

0.21

.81

0.01

Inflammation before and after 8-week ET intervention

 ESR

24.5 ± 26.33

11.5 ± 16.56

11.83 ± 13.17

6.33 ± 5.85

6.24 ± 6.66

7.19 ± 7.77

8.69

.01

0.19

3.02

.06

0.14

4.21

.02

0.19

 Albumin

24.83 ± 17.31

28.42 ± 19.24

20.37 ± 18.77

23.28 ± 18.73

23.14 ± 18.69

28.58 ± 17.99

2.47

.12

0.06

0.27

.76

0.01

0.14

.87

0.01

 CRP

4.44 ± 5.57

0.9 ± 0.85

3.02 ± 4.56

0.63 ± 0.86

0.72 ± 0.87

0.92 ± 1.56

10.40

.00

0.23

2.31

.11

0.12

4.47

.02

0.20

 Cortisol

214.67 ± 85.67

161.83 ± 79.75

248.31 ± 138.53

227.54 ± 111.15

209.05 ± 109.93

222.33 ± 99.53

0.92

.34

0.02

0.61

.55

0.03

0.88

.42

0.05

 Hemoglobin

133.33 ± 11.55

136.5 ± 9.71

135.31 ± 15.63

135.54 ± 13.85

135.5 ± 12.16

133.68 ± 12.04

0.23

.64

0.01

0.02

.98

0.00

1.66

.20

0.08

 Erytrozyten

4.78 ± 0.33

4.86 ± 0.42

4.87 ± 0.51

4.87 ± 0.44

4.85 ± 0.35

4.77 ± 0.25

0.03

.85

0.00

0.05

.95

0.00

0.80

.46

0.04

  1. IBD-AD IBD in an active state of the disease, IBD-RE IBD in remission, HC Healthy Control, BSG Blood Sedimentation Grade, CRP C-Reactive Protein
  2. Notes. N = 44; degrees of freedom always = 2, 41; p < .05 statistically significant; all data presented in mean (M) ± standard deviation; effect sizes: small (s) = .01 ≤ ηp2 ≤ .059, medium (m) = .06 ≤ ηp2 ≤ .139, or large (l) = ηp2 ≥ .14
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us